Thomas Brunner#

• since 2022 Chair of Board of Directors, Biotechnology Institute Thurgau, Kreuzlingen, Switzerland
• since 2020 Professor and Chair of Biochemical Pharmacology, University of Konstanz, Germany
• 2007 - 2010 Associate Professor, Institute of Pathology, University of Bern, Switzerland
• 2000 - 2007 Assistant Professor, Institute of Pathology, University of Bern, Switzerland
• 1997 - 2010 Independent Research Group Leader, Institute of Pathology, University of Bern, Switzerland
• 1993 - 1997 Postdoctoral Fellow, La Jolla Institute for Allergy and Immunology, San Diego, CA
• 1992 - 1993 Postdoctoral Fellow, Institute of Clinical Immunology, University of Bern, Switzerland
• 1990 - 1992 PhD Thesis, Institute of Clinical Immunology, University of Bern, Switzerland
• 1988 - 1989 Master Thesis, Theodor Kocher Institute, university of Bern, Switzerland

• Nuclear receptors
• Immunology
• TNF family
• BCL-2 family
• Glucocorticoids
• Cell death
• Inflammation

• Since 2020 Spokesperson of the DFG-funded Transregio-Collaborative Research Center TRR 353 "Death Decisions"
• 2011 - 2020 Spokesperson of the DFG-funded FOR20236 Research Group "New insight into Bcl-2 family interactions: from biophysics to function"
• 2004 - 2007 Swiss Coordinator of COST Action 844
• 2002 Theodor Kocher Award, University of Bern, Switzerland
• 1995 Fellowship Swiss Society for Medical and Biological Fellowships
• 1995 Roche Research Foundation Fellowship
• 1994 Ciba (Novartis) Annerversary Foundation Fellowship
• 1993 Swiss National Science Foundation Fellowship
• 1992 Pharmacia Allergy Foundation Award

Curriculum Vitae

---

Publication list

---

Highlights of my work and anecdotes

---

Other information